Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Moderna, Inc. (MRNA) Price & Performance

ADMA Biologics IncTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Moderna, Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Moderna, Inc. trades at $60.5 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 10.9× ADMA Biologics Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAMRNA
Market Cap
$2.22B$24.18B
Sector
HealthHealth
52-Week High
$20.38$81.80
52-Week Low
$7.60$22.36
Enterprise Value
$2.29B$20.33B

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA